Abstract
The therapeutic application of cannabinoids has gained traction in recent years. Cannabinoids interact with the human endocannabinoid system in the skin. A large body of research indicates that cannabinoids could hold promise for the treatment of eczema, psoriasis, acne, pruritus, hair disorders, and skin cancer. However, most of the available data are at the preclinical stage. Comprehensive, large-scale, randomized, controlled clinical trials have not yet been fully conducted. In this article, we describe new findings in cannabinoid research and point out promising future research areas.
| Original language | English |
|---|---|
| Article number | 16523 |
| Journal | International Journal of Molecular Sciences |
| Volume | 24 |
| Issue number | 22 |
| DOIs | |
| State | Published - Nov 2023 |
Bibliographical note
Publisher Copyright:© 2023 by the authors.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- acne
- atopic dermatitis
- cannabidiol (CBD)
- cannabinoid receptor 1 (CB1R)
- cannabinoid receptor 2 (CB2R)
- cannabinoids
- eczema
- endocannabinoids
- hair growth
- psoriasis
- skin aging
Fingerprint
Dive into the research topics of 'Cannabinoids and Their Receptors in Skin Diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver